|
WO2021078221A1
|
|
Dihydropyrimidine compound and use thereof in drug
|
|
WO2021078135A1
|
|
Pyrrole amide compound and use thereof
|
|
WO2021078077A1
|
|
New crystal form of acetylated eltrombopag and preparation method therefor
|
|
WO2021078076A1
|
|
Novel crystalline form of acetylated eltrombopag and preparation method thereof
|
|
WO2021073548A1
|
|
Pharmaceutical composition
|
|
WO2021057970A1
|
|
Ret inhibitor, pharmaceutical composition thereof and use thereof
|
|
WO2021057963A1
|
|
Ret inhibitor, pharmaceutical composition comprising same and use thereof
|
|
WO2021057881A1
|
|
Oseltamivir preparation
|
|
WO2021057834A1
|
|
Crystal form of ester compound and preparation method therefor
|
|
WO2021057791A1
|
|
Chemical compound as thyroid hormone beta receptor agonist and use thereof
|
|
WO2021043209A1
|
|
Ret inhibitor, pharmaceutical composition and use thereof
|
|
WO2021043185A1
|
|
A compound as a thyroid hormone beta receptor agonist and use thereof
|
|
WO2021027795A1
|
|
Chimeric antigen receptors and uses thereof
|
|
WO2021013217A1
|
|
A teixobactin analogue and use thereof
|
|
WO2021004498A1
|
|
Glucopyranosyl derivatives and their uses
|
|
WO2020259366A1
|
|
Crystal form of coagulation factor xia inhibitor and preparation method therefor
|
|
WO2020238998A1
|
|
Anti-trka antibodies and uses thereof
|
|
WO2020233583A1
|
|
Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof
|
|
WO2020177715A1
|
|
Influenza virus replication inhibitor and use thereof
|
|
WO2020173346A1
|
|
Method for preparing siponimod
|
